---
figid: PMC9255247__cdr-5-2-459.fig.2
figtitle: Prostate cancer stem-like cells in the development of antiandrogen resistance
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC9255247
filename: cdr-5-2-459.fig.2.jpg
figlink: /pmc/articles/PMC9255247/figure/fig2/
number: F2
caption: 'Signaling pathways regulating CSCs and the use of inhibitors in suppressing
  these pathways. These molecules thereof could be developed as potential therapeutics.
  The denotes in the figure are: Hedgehog signaling pathway (HH), notch intracellular
  domain (NICD), phosphorylation (P), smoothened (SMO), Wnt signaling pathways (Wnt),
  nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
  (IkBα), RELA Proto-Oncogene (RelA), Frizzled (FZD), casein kinase I (CKI), Axin
  (AXIN), APC Regulator of WNT Signaling Pathway (APC), Dishevelled (Dvl), Glycogen
  Synthase Kinase (GSK), IkappaB Kinase (IKK).'
papertitle: Role of prostate cancer stem-like cells in the development of antiandrogen
  resistance.
reftext: Prem Prakash Kushwaha, et al. Cancer Drug Resist. 2022;5(2):459-471.
year: '2022'
doi: 10.20517/cdr.2022.07
journal_title: Cancer Drug Resistance
journal_nlm_ta: Cancer Drug Resist
publisher_name: OAE Publishing Inc.
keywords: Prostate cancer | second-generation antiandrogens | cancer stem cells |
  castration resistance prostate cancer | androgen deprivation therapy
automl_pathway: 0.9518349
figid_alias: PMC9255247__F2
figtype: Figure
redirect_from: /figures/PMC9255247__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9255247__cdr-5-2-459.fig.2.html
  '@type': Dataset
  description: 'Signaling pathways regulating CSCs and the use of inhibitors in suppressing
    these pathways. These molecules thereof could be developed as potential therapeutics.
    The denotes in the figure are: Hedgehog signaling pathway (HH), notch intracellular
    domain (NICD), phosphorylation (P), smoothened (SMO), Wnt signaling pathways (Wnt),
    nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor,
    alpha (IkBα), RELA Proto-Oncogene (RelA), Frizzled (FZD), casein kinase I (CKI),
    Axin (AXIN), APC Regulator of WNT Signaling Pathway (APC), Dishevelled (Dvl),
    Glycogen Synthase Kinase (GSK), IkappaB Kinase (IKK).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - kita
  - ngfra
  - cki
  - apc
  - ctnnb1
  - rela
  - nfkb1
  - smo
  - gli
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - CHKA
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - CTNNB1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - RELA
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - PTCH1
  - SMO
  - SMOX
  - GLI1
  - CELP
---
